JP4727990B2 - モルヒネ−６−グルクロニドの塩 - Google Patents

モルヒネ−６−グルクロニドの塩 Download PDF

Info

Publication number
JP4727990B2
JP4727990B2 JP2004528672A JP2004528672A JP4727990B2 JP 4727990 B2 JP4727990 B2 JP 4727990B2 JP 2004528672 A JP2004528672 A JP 2004528672A JP 2004528672 A JP2004528672 A JP 2004528672A JP 4727990 B2 JP4727990 B2 JP 4727990B2
Authority
JP
Japan
Prior art keywords
hbr
solution
morphine
organic solvent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004528672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500360A (ja
JP2006500360A5 (OSRAM
Inventor
エイトケン グラハム，ジョン
フランツマイアー，ルドルフ
コホ，アンドレアス
シュナイダー，ヘルビク
Original Assignee
セネス リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セネス リミティド filed Critical セネス リミティド
Publication of JP2006500360A publication Critical patent/JP2006500360A/ja
Publication of JP2006500360A5 publication Critical patent/JP2006500360A5/ja
Application granted granted Critical
Publication of JP4727990B2 publication Critical patent/JP4727990B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2004528672A 2002-08-14 2003-08-14 モルヒネ−６−グルクロニドの塩 Expired - Fee Related JP4727990B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0218811.8A GB0218811D0 (en) 2002-08-14 2002-08-14 Salts of morphine-6-glucuronide
GB0218811.8 2002-08-14
PCT/GB2003/003562 WO2004016633A1 (en) 2002-08-14 2003-08-14 Salt of morphine-6-glucuronide

Publications (3)

Publication Number Publication Date
JP2006500360A JP2006500360A (ja) 2006-01-05
JP2006500360A5 JP2006500360A5 (OSRAM) 2006-09-28
JP4727990B2 true JP4727990B2 (ja) 2011-07-20

Family

ID=9942230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004528672A Expired - Fee Related JP4727990B2 (ja) 2002-08-14 2003-08-14 モルヒネ−６−グルクロニドの塩

Country Status (17)

Country Link
US (1) US20060166900A1 (OSRAM)
EP (1) EP1537132B1 (OSRAM)
JP (1) JP4727990B2 (OSRAM)
KR (1) KR101077501B1 (OSRAM)
AT (1) ATE315041T1 (OSRAM)
AU (1) AU2003255790B2 (OSRAM)
CA (1) CA2494812C (OSRAM)
DE (1) DE60303149T2 (OSRAM)
DK (1) DK1537132T3 (OSRAM)
EA (1) EA008212B1 (OSRAM)
ES (1) ES2256790T3 (OSRAM)
GB (1) GB0218811D0 (OSRAM)
IL (1) IL166596A0 (OSRAM)
NO (1) NO20051261L (OSRAM)
PL (1) PL211031B1 (OSRAM)
WO (1) WO2004016633A1 (OSRAM)
ZA (1) ZA200501053B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578626C (en) 2005-06-27 2011-07-19 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
FR2939437B1 (fr) * 2008-12-10 2010-12-17 Sanofi Aventis Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique
FR2939796B1 (fr) * 2008-12-11 2010-12-17 Sanofi Aventis Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique
CN107028968B (zh) * 2016-02-03 2020-12-04 江苏恒瑞医药股份有限公司 一种含有葡萄糖醛酸吗啡或其可药用盐的药物组合物
CA3041308A1 (en) 2016-10-21 2018-04-26 Somniferum Labs LLC Method, system and apparatus for controlled delivery of opioid and other medications
CN110054656B (zh) * 2019-05-28 2021-02-02 宜昌人福药业有限责任公司 一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
CN113831373B (zh) * 2020-06-23 2023-05-16 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖苷酸脱水物杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
FR2680786B1 (fr) * 1991-09-04 1995-03-10 Irepa Procede de synthese de glucuronides d'epoxy-4,5 morphinanes.
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
WO1997021416A2 (es) * 1995-11-29 1997-06-19 Rolabo Sl Glicoconjugados de substancias opiaceas
IL134787A (en) * 1997-09-25 2007-05-15 Lohmann Therapie Syst Lts Acid addition salts of morphine alkaloids, their preparation and pharmaceutical compositions containing them for trandermal and transmucosal application
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain

Also Published As

Publication number Publication date
AU2003255790B2 (en) 2010-05-27
ZA200501053B (en) 2005-10-26
JP2006500360A (ja) 2006-01-05
CA2494812C (en) 2011-03-08
PL373553A1 (en) 2005-09-05
EP1537132A1 (en) 2005-06-08
CA2494812A1 (en) 2004-02-26
PL211031B1 (pl) 2012-04-30
DE60303149T2 (de) 2006-09-28
KR20050055710A (ko) 2005-06-13
EA200500175A1 (ru) 2005-08-25
ES2256790T3 (es) 2006-07-16
DE60303149D1 (de) 2006-03-30
KR101077501B1 (ko) 2011-10-28
US20060166900A1 (en) 2006-07-27
ATE315041T1 (de) 2006-02-15
NO20051261L (no) 2005-03-11
AU2003255790A1 (en) 2004-03-03
EP1537132B1 (en) 2006-01-04
GB0218811D0 (en) 2002-09-18
EA008212B1 (ru) 2007-04-27
WO2004016633A1 (en) 2004-02-26
DK1537132T3 (da) 2006-05-08
IL166596A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
EP0193926B3 (en) Phenyl carbamates
JP4727990B2 (ja) モルヒネ−６−グルクロニドの塩
CN103788043B (zh) 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途
CN100425289C (zh) 紫衫醇的2-羟基丙基-β-环糊精包合配合物
CN108883101A (zh) 野靛碱的琥珀酸盐及其用途
CN103330688B (zh) 治疗胃病的雷尼替丁冻干粉针剂
EP3995134A1 (en) Micromolecule pi4kiiialpha inhibitor composition, preparation method therefor and use thereof
EP0586917A1 (de) Substituierte Phenole, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von zellproliferationsbedingten Erkrankungen
EP3553059A1 (en) Hydrobromate of benzodiazepine derivative, preparation method and use thereof
US20050202050A1 (en) Single tank process for preparing tannate liquid and semi-solid dosage forms
US6528524B2 (en) Pharmaceutical compositions containing cinchonine dichlorhydrate
CN109984996A (zh) 恩替卡韦口服溶液及其制备方法
US20200276207A1 (en) Injectable carbamazepine composition essentially free of 10-bromo-carbamazepine
EP4628082A1 (en) Pharmaceutical composition of kappa opioid receptor agonist, preparation method therefor, and use thereof
KR20210141203A (ko) 에르도스테인 유도체 및 이를 함유하는 약학 조성물
KR20200094485A (ko) 모노메틸 푸마레이트 전구체 약물 화합물 및 이들의 약학적 조성물
KR20140145508A (ko) 암브록솔 및 레보드로프로피진을 포함하는 안정성이 개선된 경구용 액상 제제
CN113262199A (zh) 一种伊曲康唑口服液及其制备方法
EP0461696B1 (en) Crystalline polypeptides with corticotropic activity
KR20250019706A (ko) 조성물 및 방법(composition and method)
US20040235884A1 (en) Preventives/remedies for cholinergic neuropathy
HK40073830A (en) Micromolecule pi4kiiialpha inhibitor composition, preparation method therefor and use thereof
US20040198667A1 (en) Hot melt method for preparing diphenhydramine tannate
CN104844530A (zh) 一种新的六甲蜜胺盐的制备及其药物组合物与临床应用
CN112121007A (zh) 一种酒石酸阿利美嗪的口服液制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060811

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060811

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100316

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100615

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100816

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110315

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110414

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140422

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees